{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:22:54Z","timestamp":1790281374648,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.bcmd.2010.07.011","type":"journal-article","created":{"date-parts":[[2010,8,22]],"date-time":"2010-08-22T04:47:29Z","timestamp":1282452449000},"page":"192-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["BAX\/BCL-XL gene expression ratio inversely correlates with disease progression in chronic myeloid leukemia"],"prefix":"10.1016","volume":"45","author":[{"given":"Mariana S.","family":"Gonzalez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos D.","family":"De Brasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Bianchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Gargallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Moiraghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Bengi\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene B.","family":"Larripa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2010.07.011_bb0005","first-page":"2405","article-title":"Cell kinetics and growth of squamous cell carcinomas in man","volume":"34","author":"Bresciani","year":"1974","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcmd.2010.07.011_bb0010","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1158\/1078-0432.CCR-04-1973","article-title":"Minimal residual disease in acute myeloid leukemia is predicted by an apoptosis-resistant protein profile at diagnosis","volume":"11","author":"Van Stijn","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcmd.2010.07.011_bb0015","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1182\/blood.V81.11.3091.3091","article-title":"High expression of bcl2 protein in acute myeloid leukemia is associated with poor response to chemotherapy","volume":"81","author":"Campos","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2010.07.011_bb0020","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1038\/sj.leu.2400854","article-title":"High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate","volume":"11","author":"Lauria","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2010.07.011_bb0025","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1038\/sj.leu.2401605","article-title":"Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function maturation stage and cytogenetics","volume":"13","author":"Wuchter","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2010.07.011_bb0030","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1365-2141.2000.02315.x","article-title":"High bax expression is a good prognostic indicator in acute myeloid leukaemia","volume":"111","author":"Ong","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2010.07.011_bb0035","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1182\/blood.V87.9.3837.bloodjournal8793837","article-title":"Apoptosis induced by erythroid differentiation of human leukemia cell lines is inhibited by Bcl-XL","volume":"87","author":"Benito","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2010.07.011_bb0040","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/sj.onc.1201664","article-title":"BCL-2 independent BCR-ABL mediated resistance to apoptosis protection is correlated with up regulation of BCL-XL","volume":"16","author":"Amarante-Mendez","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.bcmd.2010.07.011_bb0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000096858","article-title":"Changes in expression of apoptosis-related genes are linked to the molecular response to imatinib treatment in chronic-phase chronic myeloid leukemia patients","volume":"117","author":"Wei","year":"2007","journal-title":"Acta Hematol."},{"key":"10.1016\/j.bcmd.2010.07.011_bb0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.0902-4441.2003.00201.x","article-title":"Differences in BCL-XL expression and STAT5 phosphorylation in chronic myeloid leukemia patients","volume":"72","author":"Gutierrez-Castellanos","year":"2004","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bcmd.2010.07.011_bb0055","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood.V45.3.321.321","article-title":"Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome","volume":"45","author":"Lozzio","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2010.07.011_bb0060","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1525-1578(10)60007-4","article-title":"Single monochrome real-time RT-PCR assay for identification, quantification and breakpoint cluster region determination of t(9;22) transcripts","volume":"7","author":"Gutierrez","year":"2005","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.bcmd.2010.07.011_bb0065","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/sj.leu.2403136","article-title":"Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using \u201creal-time\u201d quantitative reverse-transcriptase polymerase chain reaction (RQ_PCR)\u2014a Europe against cancer program","volume":"17","author":"Beillard","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2010.07.011_bb0070","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1182\/blood-2006-02-005686","article-title":"Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European Leukemia Net","volume":"108","author":"Baccarani","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2010.07.011_bb0075","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199907153410306","article-title":"The biology of chronic myeloid leucemias","volume":"341","author":"Faderl","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.bcmd.2010.07.011_bb0080","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.4161\/auto.5.7.9509","article-title":"Targeted therapies and autophagy: new insights from chronic myeloid leukemia","volume":"5","author":"Salomoni","year":"2009","journal-title":"Autophagy"},{"key":"10.1016\/j.bcmd.2010.07.011_bb0085","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1600-0609.2008.01199.x","article-title":"Specifc assessment of bcr-abl transcript overexpression and imatinib resistance in chronic myeloid leukemia patients","volume":"82","author":"Bianchini","year":"2009","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bcmd.2010.07.011_bb0090","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0165-4608(02)00854-3","article-title":"Amplification of the BCR\/ABL fusion gene clustered on a masked PH chromosome in a patient with myelocitic blast crisis of chronic myelocytic leukemia","volume":"143","author":"Gargallo","year":"2003","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.bcmd.2010.07.011_bb0095","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0014-5793(03)00299-0","article-title":"Comparison of the anti-apoptotic effects of BCR-ABL, BCL2 and BCL-XL following diverse apoptogenic stimuli","volume":"541","author":"Brumatti","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcmd.2010.07.011_bb0100","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1002\/1097-0142(20010601)91:11<1964::AID-CNCR1221>3.0.CO;2-B","article-title":"Expression of apoptosis proteins in chronic myelogenous leukemia: associations and significance","volume":"91","author":"Ravandi","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.bcmd.2010.07.011_bb0105","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1182\/blood-2002-06-1714","article-title":"Amount of spontaneous apoptosis detected by Bax\/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML)","volume":"101","author":"Del Poeta","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2010.07.011_bb0110","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1084\/jem.191.6.977","article-title":"Blockade of the BCR-ABL kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of BCL-XL","volume":"191","author":"Horita","year":"2000","journal-title":"J. Exp. Med."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979610001920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979610001920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:27:32Z","timestamp":1761049652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979610001920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S1079979610001920"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2010.07.011","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BAX\/BCL-XL gene expression ratio inversely correlates with disease progression in chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2010.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}